Carlisle Companies Incorporated  (CSL)
Other Ticker:  
Price: $216.8300 $1.53 0.711%
Day's High: $218.36 Week Perf: 1.61 %
Day's Low: $ 214.83 30 Day Perf: -0.38 %
Volume (M): 324 52 Wk High: $ 318.71
Volume (M$): $ 70,253 52 Wk Avg: $253.68
Open: $215.81 52 Wk Low: $203.66

 Market Capitalization (Millions $) 11,210
 Shares Outstanding (Millions) 52
 Employees 12,000
 Revenues (TTM) (Millions $) 6,274
 Net Income (TTM) (Millions $) 832
 Cash Flow (TTM) (Millions $) 132
 Capital Exp. (TTM) (Millions $) 193

Carlisle Companies Incorporated
We strive to be the market leader of highly-engineered products in the various markets we serve. We are dedicated to achieving low-cost positions and providing service excellence based on, among other things, superior quality, on-time delivery, and short cycle times.

The presidents of the various operating companies are given considerable autonomy and have a significant level of independent responsibility for their businesses and their performance. The Company believes that this structure encourages entrepreneurial action and enhances responsive decision making thereby enabling each operation to better serve its customers and react quickly to its customers’ needs.

Our executive management role is to (i) provide general management oversight and counsel, (ii) manage the Company’s portfolio of businesses including identifying acquisition candidates and assisting in acquiring candidates identified by the operating companies, as well as identifying businesses for divestiture in an effort to optimize the portfolio, (iii) allocate and manage capital, (iv) evaluate and motivate operating management personnel, and (v) provide selected other services.

   Company Address: 16430 North Scottsdale Road Scottsdale 85254 AZ
   Company Phone Number: 781-5000   Stock Exchange / Ticker: NYSE CSL
   CSL is expected to report next financial results on July 27, 2023.

Customers Net Income fell by CSL's Customers Net Profit Margin fell to

-40.91 %

8.62 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


Stock Performances by Major Competitors

5 Days Decrease / Increase
CE        0.04% 
DOW   -3.1%    
ECL   -4.77%    
EMN   -1.38%    
HON   -1.82%    
RPM      0% 
• View Complete Report

Delcath Systems Inc

Delcath Systems Inc announced the deficit has been cut back remarkably, over the January to March 31 2023 period

Investors, get ready to rejoice! Delcath Systems Inc has delivered some impressive results for the first quarter of 2023. The company reported a whopping 57.937% revenue growth to $0.60 million, which has effectively helped to bring down losses to $-0.77 per share. This is a significant improvement from the $-1.00 per share loss reported in the same quarter last year.
Despite a decline in revenue in Q4, it's worth noting that the company managed to improve its EPS from $-0.88 to $-0.77 per share in the most recent quarter. It's always a good indication when a company is able to cut losses and improve profitability.

Haemonetics Corporation

Breathtaking financial reporting period by at the Haemonetics Corporation during the February to April 01 2023 span

Investors in Haemonetics Corporation can expect solid growth and increased earnings based on the company's fiscal fourth quarter 2023 financial results. The medical equipment and supplies company reported an impressive 71.13% increase in income per share to $0.77 compared to the previous year, while revenues grew by 31.706% to $342.13 million.
The company's net earnings also saw a healthy increase of 69.37% to $39.348 million. Although operating margin fell to 13.54%, the net margin actually improved to 11.5%. Operating earnings, however, only improved by 29.97% to $46.336 million.

T2 Biosystems Inc

Extremely challenging financial reporting period for T2 Biosystems Inc during the financial period ending March 31 2023

While the stock market can be a turbulent place, there is one company that has had a rough start to 2023. T2 Biosystems Inc recently reported a substantial decrease in revenue, a net loss per share expansion, and a significant drop in sequential revenue, causing some investors to worry.
But let's take a closer look at what these numbers actually mean. While the Mar 31 2023 report was certainly a disappointment, it's important to remember that these are just one quarter's worth of financials. There are always ups and downs in the stock market, and companies often experience setbacks before bouncing back stronger than ever.

H Cyte Inc

The revenue are the similar like a year prior at the Medical Equipment and Supplies company over the January to March 31 2023 span

H Cyte Inc is a company involved in the developing and commercialization of medical therapeutics, specifically in the field of regenerative medicine. The company's focus is on developing therapies for joint and spine-related conditions. The company is headquartered in California and began trading on the NASDAQ Global Market in February 2022 under the ticker symbol HCYT.
In the first quarter of 2023, H Cyte Inc reported that its net deficit had expanded to $-3.38 per share, compared to $0.00 per share in the same period of the previous year. However, the company's EPS improved to $-5.08 per share from the previous reporting season. In terms of revenue, the company's earnings remained unchanged at $0.00 million from the previous year's reporting season and sequentially. The company also reported a net deficit of $-2.090 million in the first quarter of 2023, compared to a deficit of $-3.892 million in the same period of the previous year.

Therapeutic Solutions International Inc

Severe hit for Therapeutic Solutions International Inc all along the financial span ending March 31 2023

Therapeutic Solutions International Inc, a pharmaceutical company, recently published its fiscal interval report ending on March 31, 2023. The report indicated that the company was able to maintain balanced books, showing no earnings or losses per share. This is the same as the previous fiscal year, but an improvement from the previous reporting period.
The company's revenue, on the other hand, decreased by 72.764% from $0.08 million in the comparative period to $0.02 million. However, sequentially, there was a significant increase of 169.53% from $0.01 million. This indicates that the company's financial performance has been unstable overall.


Carlisle Companies Incorporated's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071